Tenaya Therapeutics, Inc.
NASDAQ:TNYA
0.6702 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 4.323 | 45.681 | 95.272 | 38.129 | 128.535 | 23.872 |
| Short Term Investments
| 57.123 | 58.961 | 91.255 | 213.171 | 0 | 2.753 |
| Cash and Short Term Investments
| 61.446 | 104.642 | 204.23 | 251.3 | 128.535 | 26.625 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | -19.948 | 0 | 0 | 0 |
| Other Current Assets
| 5.929 | 6.94 | 11.271 | 8.116 | 1.429 | 1.117 |
| Total Current Assets
| 67.375 | 111.582 | 193.754 | 255.358 | 129.964 | 27.742 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 47.748 | 53.256 | 62.695 | 54.705 | 17.185 | 9.575 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | -3.005 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 17.703 | 0.547 | 0.634 | 0.485 |
| Tax Assets
| 0 | 0 | 0 | 2.458 | 0 | 0 |
| Other Non-Current Assets
| 4.817 | 5.677 | 4.793 | 4.126 | 0.378 | 0.199 |
| Total Non-Current Assets
| 52.565 | 58.933 | 85.191 | 58.831 | 18.197 | 10.259 |
| Total Assets
| 119.94 | 170.515 | 278.945 | 314.189 | 148.161 | 38.001 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 5.162 | 5.63 | 9.578 | 10.721 | 1.017 | 0.6 |
| Short Term Debt
| 2.778 | 4.319 | 8.012 | 3.988 | 0 | 0 |
| Tax Payables
| 0.348 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 8.897 | 0 | 0 |
| Other Current Liabilities
| 7.687 | 12.784 | 6.658 | 7.065 | 4.024 | 3.52 |
| Total Current Liabilities
| 15.975 | 22.733 | 24.248 | 21.774 | 5.041 | 4.12 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 10.83 | 8.105 | 11.093 | 13.707 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | -2.458 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 2.458 | 0 | 0 |
| Other Non-Current Liabilities
| 0.281 | 0.253 | 0.228 | 0.182 | 224.435 | 77.62 |
| Total Non-Current Liabilities
| 11.111 | 8.358 | 11.321 | 13.889 | 224.435 | 77.62 |
| Total Liabilities
| 27.086 | 31.091 | 278.945 | 35.663 | 229.476 | 81.74 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 314.189 | 0.221 | 0.073 |
| Common Stock
| 0.008 | 0.007 | 0.007 | 0.004 | 0.001 | 0.001 |
| Retained Earnings
| -514.411 | -403.282 | -279.198 | -155.533 | -82.812 | -44.417 |
| Accumulated Other Comprehensive Income/Loss
| 0.028 | -0.106 | -0.378 | -0.141 | -0.222 | -0.074 |
| Other Total Stockholders Equity
| 607.229 | 542.805 | 522.945 | 434.196 | 1.585 | 0.789 |
| Total Shareholders Equity
| 92.854 | 139.424 | 243.376 | 278.526 | -81.315 | -43.739 |
| Total Equity
| 92.854 | 139.424 | 243.376 | 278.526 | -81.315 | -43.739 |
| Total Liabilities & Shareholders Equity
| 119.94 | 170.515 | 278.945 | 314.189 | 148.161 | 38.001 |